OCA at 08:48, 14 July 2024

2024-07-14T08:48:47Z

← Older revision		Revision as of 08:48, 14 July 2024
Line 1:		Line 1:
	~~'''Unreleased structure'''~~

	The ~~entry 9eo7~~ is ~~ON HOLD~~		==PHF type tau filament from V337M mutant==
			<StructureSection load='9eo7' size='340' side='right'caption='[[9eo7]], [[Resolution\|resolution]] 2.80Å' scene=''>
			== Structural highlights ==
			<table><tr><td colspan='2'>[[9eo7]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9EO7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9EO7 FirstGlance]. <br>
			</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution\|Resolution]] 2.8Å</td></tr>
			<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9eo7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9eo7 OCA], [https://pdbe.org/9eo7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9eo7 RCSB], [https://www.ebi.ac.uk/pdbsum/9eo7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9eo7 ProSAT]</span></td></tr>
			</table>
			== Disease ==
			[https://www.uniprot.org/uniprot/TAU_HUMAN TAU_HUMAN] Note=In Alzheimer disease, the neuronal cytoskeleton in the brain is progressively disrupted and replaced by tangles of paired helical filaments (PHF) and straight filaments, mainly composed of hyperphosphorylated forms of TAU (PHF-TAU or AD P-TAU). O-GlcNAcylation is greatly reduced in Alzheimer disease brain cerebral cortex leading to an increase in TAU/MAPT phosphorylations.<ref>PMID:19451179</ref> <ref>PMID:2484340</ref> <ref>PMID:14517953</ref> Defects in MAPT are a cause of frontotemporal dementia (FTD) [MIM:[https://omim.org/entry/600274 600274]; also called frontotemporal dementia (FTD), pallido-ponto-nigral degeneration (PPND) or historically termed Pick complex. This form of frontotemporal dementia is characterized by presenile dementia with behavioral changes, deterioration of cognitive capacities and loss of memory. In some cases, parkinsonian symptoms are prominent. Neuropathological changes include frontotemporal atrophy often associated with atrophy of the basal ganglia, substantia nigra, amygdala. In most cases, protein tau deposits are found in glial cells and/or neurons.<ref>PMID:19451179</ref> <ref>PMID:2484340</ref> <ref>PMID:14517953</ref> <ref>PMID:9629852</ref> <ref>PMID:9736786</ref> <ref>PMID:9641683</ref> <ref>PMID:9789048</ref> <ref>PMID:9973279</ref> <ref>PMID:10553987</ref> <ref>PMID:10214944</ref> <ref>PMID:10374757</ref> <ref>PMID:10489057</ref> <ref>PMID:10208578</ref> <ref>PMID:11117541</ref> <ref>PMID:10802785</ref> <ref>PMID:11071507</ref> <ref>PMID:11585254</ref> <ref>PMID:11278002</ref> <ref>PMID:12473774</ref> <ref>PMID:11921059</ref> <ref>PMID:11906000</ref> <ref>PMID:11889249</ref> <ref>PMID:12509859</ref> <ref>PMID:16240366</ref> <ref>PMID:15883319</ref> Defects in MAPT are a cause of Pick disease of the brain (PIDB) [MIM:[https://omim.org/entry/172700 172700]. It is a rare form of dementia pathologically defined by severe atrophy, neuronal loss and gliosis. It is characterized by the occurrence of tau-positive inclusions, swollen neurons (Pick cells) and argentophilic neuronal inclusions known as Pick bodies that disproportionally affect the frontal and temporal cortical regions. Clinical features include aphasia, apraxia, confusion, anomia, memory loss and personality deterioration.<ref>PMID:19451179</ref> <ref>PMID:2484340</ref> <ref>PMID:14517953</ref> <ref>PMID:10604746</ref> <ref>PMID:11117542</ref> <ref>PMID:11089577</ref> <ref>PMID:11601501</ref> <ref>PMID:11891833</ref> Note=Defects in MAPT are a cause of corticobasal degeneration (CBD). It is marked by extrapyramidal signs and apraxia and can be associated with memory loss. Neuropathologic features may overlap Alzheimer disease, progressive supranuclear palsy, and Parkinson disease.<ref>PMID:19451179</ref> <ref>PMID:2484340</ref> <ref>PMID:14517953</ref> Defects in MAPT are a cause of progressive supranuclear palsy type 1 (PSNP1) [MIM:[https://omim.org/entry/601104 601104]; also abbreviated as PSP and also known as Steele-Richardson-Olszewski syndrome. PSNP1 is characterized by akinetic-rigid syndrome, supranuclear gaze palsy, pyramidal tract dysfunction, pseudobulbar signs and cognitive capacities deterioration. Neurofibrillary tangles and gliosis but no amyloid plaques are found in diseased brains. Most cases appear to be sporadic, with a significant association with a common haplotype including the MAPT gene and the flanking regions. Familial cases show an autosomal dominant pattern of transmission with incomplete penetrance; genetic analysis of a few cases showed the occurrence of tau mutations, including a deletion of Asn-613.<ref>PMID:19451179</ref> <ref>PMID:2484340</ref> <ref>PMID:14517953</ref> <ref>PMID:10534245</ref> <ref>PMID:11220749</ref> <ref>PMID:12325083</ref> <ref>PMID:14991829</ref> <ref>PMID:14991828</ref> <ref>PMID:16157753</ref> Defects in MAPT are a cause of Parkinson-dementia syndrome (PARDE) [MIM:[https://omim.org/entry/260540 260540]. A syndrome characterized by parkinsonism tremor, rigidity, dementia, ophthalmoparesis and pyramidal signs. Neurofibrillary degeneration occurs in the hippocampus, basal ganglia and brainstem nuclei.<ref>PMID:19451179</ref> <ref>PMID:2484340</ref> <ref>PMID:14517953</ref>
			== Function ==
			[https://www.uniprot.org/uniprot/TAU_HUMAN TAU_HUMAN] Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.<ref>PMID:21985311</ref>
			<div style="background-color:#fffaf0;">
			== Publication Abstract from PubMed ==
			Frontotemporal dementia (FTD) and Alzheimer's disease are the most common forms of early-onset dementia. Dominantly inherited mutations in MAPT, the microtubule-associated protein tau gene, cause FTD and parkinsonism linked to chromosome 17 (FTDP-17). Individuals with FTDP-17 develop abundant filamentous tau inclusions in brain cells. Here we used electron cryo-microscopy to determine the structures of tau filaments from the brains of individuals with MAPT mutations V337M and R406W. Both mutations gave rise to tau filaments with the Alzheimer fold, which consisted of paired helical filaments in all V337M and R406W cases and of straight filaments in two V337M cases. We also identified a new assembly of the Alzheimer fold into triple tau filaments in a V337M case. Filaments assembled from recombinant tau(297-391) with mutation V337M had the Alzheimer fold and showed an increased rate of assembly.

	~~Authors:~~ Qi, C., Scheres, S.H.W., ~~Michel, G~~.		Tau filaments with the Alzheimer fold in cases with MAPT mutations V337M and R406W.,Qi C, Lovestam S, Murzin AG, Peak-Chew S, Franco C, Bogdani M, Latimer C, Murrell JR, Cullinane PW, Jaunmuktane Z, Bird TD, Ghetti B, Scheres SHW, Goedert M bioRxiv [Preprint]. 2024 Apr 30:2024.04.29.591661. doi: , 10.1101/2024.04.29.591661. PMID:38746388<ref>PMID:38746388</ref>

	~~Description~~: ~~PHF type tau filament from V337M mutant~~		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	[[Category: ~~Unreleased~~ Structures]]		</div>
	[[Category: Michel, G]]		<div class="pdbe-citations 9eo7" style="background-color:#fffaf0;"></div>
	[[Category: Qi, C]]		== References ==
	[[Category: Scheres~~, S.H.W~~]]		<references/>
			__TOC__
			</StructureSection>
			[[Category: Homo sapiens]]
			[[Category: Large Structures]]
			[[Category: Michel G]]
			[[Category: Qi C]]
			[[Category: Scheres SHW]]

OCA at 15:13, 29 May 2024

2024-05-29T15:13:19Z

← Older revision		Revision as of 15:13, 29 May 2024
Line 8:		Line 8:
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
	[[Category: Michel, G]]		[[Category: Michel, G]]
			[[Category: Qi, C]]
	[[Category: Scheres, S.H.W]]		[[Category: Scheres, S.H.W]]
	~~[[Category: Qi, C]]~~

OCA: Protected "9eo7" [edit=sysop:move=sysop]

2024-03-20T07:30:19Z

Protected "9eo7" [edit=sysop:move=sysop]

← Older revision	Revision as of 07:30, 20 March 2024
(No difference)

OCA: New page: '''Unreleased structure''' The entry 9eo7 is ON HOLD Authors: Qi, C., Scheres, S.H.W., Michel, G. Description: PHF type tau filament from V337M mutant [[Category: Unreleased Structures...

2024-03-20T07:30:18Z

New page: '''Unreleased structure''' The entry 9eo7 is ON HOLD Authors: Qi, C., Scheres, S.H.W., Michel, G. Description: PHF type tau filament from V337M mutant [[Category: Unreleased Structures...

New page

'''Unreleased structure'''

The entry 9eo7 is ON HOLD

Authors: Qi, C., Scheres, S.H.W., Michel, G.

Description: PHF type tau filament from V337M mutant
[[Category: Unreleased Structures]]
[[Category: Michel, G]]
[[Category: Scheres, S.H.W]]
[[Category: Qi, C]]

9eo7 - Revision history

OCA at 08:48, 14 July 2024

OCA at 15:13, 29 May 2024

OCA: Protected "9eo7" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 9eo7 is ON HOLD Authors: Qi, C., Scheres, S.H.W., Michel, G. Description: PHF type tau filament from V337M mutant [[Category: Unreleased Structures...